BACKGROUND AND PURPOSE: Two oxidation products of linoleic acid, 9- and 13-hydroxy-octadecadienoic acids (HODEs), have recently been suggested to act as endovanilloids, that is, endogenous agonists of transient receptor potential vanilloid-1 (TRPV1) channels, thereby contributing to inflammatory hyperalgesia in rats. However, HODE activity at rat TRPV1 in comparison with the best established endovanilloid, anandamide, and its enantioselectivity and selectivity towards other TRP channels that are also abundant in sensory neurons have never been investigated. EXPERIMENTAL APPROACH: We studied the effect of 9(R)-HODE, 9(S)-HODE, (+/-)13-HODE, 15(S)-hydroxyanandamide and anandamide on [Ca(2+) ](i) in HEK-293 cells stably expressing the rat or human recombinant TRPV1, or rat recombinant TRPV2, TRPA1 or TRPM8, and also the effect of 9(S)-HODE in rat dorsal root ganglion (DRG) neurons by calcium imaging. KEY RESULTS: Anandamide and 15(S)-hydroxyanandamide were the most potent endovanilloids at human TRPV1, whereas 9(S)-HODE was approximately threefold less efficacious and 75- and 3-fold less potent, respectively, and did not perform much better at rat TRPV1. The 9(R)-HODE and (+/-)13-HODE were almost inactive at TRPV1. Unlike anandamide and 15(S)-hydroxyanandamide, all HODEs were very weak at desensitizing TRPV1 to the action of capsaicin, but activated rat TRPV2 [only (+/-)13-HODE] and rat TRPA1, and antagonized rat TRPM8, at concentrations higher than those required to activate TRPV1. Finally, 9(S)-HODE elevated [Ca(2+) ](i) in DRG neurons almost exclusively in capsaicin-sensitive cells but only at concentrations between 25 and 100 μM. CONCLUSIONS AND IMPLICATIONS: The present data suggest that HODEs are less important endovanilloids than anandamide. LINKED ARTICLES: This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8.
BACKGROUND AND PURPOSE: Two oxidation products of linoleic acid, 9- and 13-hydroxy-octadecadienoic acids (HODEs), have recently been suggested to act as endovanilloids, that is, endogenous agonists of transient receptor potential vanilloid-1 (TRPV1) channels, thereby contributing to inflammatory hyperalgesia in rats. However, HODE activity at ratTRPV1 in comparison with the best established endovanilloid, anandamide, and its enantioselectivity and selectivity towards other TRP channels that are also abundant in sensory neurons have never been investigated. EXPERIMENTAL APPROACH: We studied the effect of 9(R)-HODE, 9(S)-HODE, (+/-)13-HODE, 15(S)-hydroxyanandamide and anandamide on [Ca(2+) ](i) in HEK-293 cells stably expressing the rat or human recombinant TRPV1, or rat recombinant TRPV2, TRPA1 or TRPM8, and also the effect of 9(S)-HODE in rat dorsal root ganglion (DRG) neurons by calcium imaging. KEY RESULTS:Anandamide and 15(S)-hydroxyanandamide were the most potent endovanilloids at humanTRPV1, whereas 9(S)-HODE was approximately threefold less efficacious and 75- and 3-fold less potent, respectively, and did not perform much better at ratTRPV1. The 9(R)-HODE and (+/-)13-HODE were almost inactive at TRPV1. Unlike anandamide and 15(S)-hydroxyanandamide, all HODEs were very weak at desensitizing TRPV1 to the action of capsaicin, but activated ratTRPV2 [only (+/-)13-HODE] and ratTRPA1, and antagonized ratTRPM8, at concentrations higher than those required to activate TRPV1. Finally, 9(S)-HODE elevated [Ca(2+) ](i) in DRG neurons almost exclusively in capsaicin-sensitive cells but only at concentrations between 25 and 100 μM. CONCLUSIONS AND IMPLICATIONS: The present data suggest that HODEs are less important endovanilloids than anandamide. LINKED ARTICLES: This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8.
Authors: S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205
Authors: M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius Journal: Science Date: 2000-04-14 Impact factor: 47.728
Authors: Mario van der Stelt; J Albert van Kuik; Monica Bari; Guus van Zadelhoff; Bas R Leeflang; Gerrit A Veldink; Alessandro Finazzi-Agrò; Johannes F G Vliegenthart; Mauro Maccarrone Journal: J Med Chem Date: 2002-08-15 Impact factor: 7.446
Authors: Constance J Chu; Susan M Huang; Luciano De Petrocellis; Tiziana Bisogno; Scott A Ewing; Jeffrey D Miller; Robert E Zipkin; Nives Daddario; Giovanni Appendino; Vincenzo Di Marzo; J Michael Walker Journal: J Biol Chem Date: 2003-02-04 Impact factor: 5.157
Authors: Susan M Huang; Tiziana Bisogno; Marcello Trevisani; Abdulmonem Al-Hayani; Luciano De Petrocellis; Filomena Fezza; Michele Tognetto; Timothy J Petros; Jocelyn F Krey; Constance J Chu; Jeffrey D Miller; Stephen N Davies; Pierangelo Geppetti; J Michael Walker; Vincenzo Di Marzo Journal: Proc Natl Acad Sci U S A Date: 2002-06-11 Impact factor: 11.205
Authors: E Mezey; Z E Tóth; D N Cortright; M K Arzubi; J E Krause; R Elde; A Guo; P M Blumberg; A Szallasi Journal: Proc Natl Acad Sci U S A Date: 2000-03-28 Impact factor: 11.205
Authors: Christopher E Ramsden; Daisy Zamora; Alexandros Makriyannis; JodiAnne T Wood; J Douglas Mann; Keturah R Faurot; Beth A MacIntosh; Sharon F Majchrzak-Hong; Jacklyn R Gross; Amber B Courville; John M Davis; Joseph R Hibbeln Journal: J Pain Date: 2015-05-07 Impact factor: 5.820
Authors: Mohammad Alsalem; Amy Wong; Paul Millns; Pallavi Huma Arya; Michael Siang Liang Chan; Andrew Bennett; David A Barrett; Victoria Chapman; David A Kendall Journal: Br J Pharmacol Date: 2013-04 Impact factor: 8.739
Authors: Amy Wong; Devi R Sagar; Catharine A Ortori; David A Kendall; Victoria Chapman; David A Barrett Journal: J Lipid Res Date: 2014-07-25 Impact factor: 5.922